에 대한 최신 뉴스 Sera Prognostics (NASDAQ:SERA) 주식

Sera Prognostics

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.

Exclusives

Trading Ideas

SCHD

SERA

매주, ‘벤징가의 스톡 위스퍼 지수(Benzinga&#39;s Stock Whisper Index)&#39;는 독점 데이터(proprietary data)와 패턴 인식의 조합을 사용하여 표면 바로 아래에서 주목을 받을 만한 주식 5종목을 소개한다.

벤징가의 &#39;스톡 위스퍼&#39; 지수: 애질런트, 트레이드 데스크, 리인슈런스, 세라 및 슈왑 ETF

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics Inc

Serabi Gold PLC

Barclays analyst David Anderson reinstates National Energy Services (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NESR#NASDAQ">NESR</a>) with a Overweight and announces $16 price target.

News

Price Target

Initiation

Analyst Ratings

NESR

Barclays Reinstates Overweight on National Energy Services, Announces $16 Price Target

JP Morgan analyst Cory Carpenter initiates coverage on ODDITY Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) with a Overweight rating and announces Price Target of $55.

JP Morgan Initiates Coverage On ODDITY Tech with Overweight Rating, Announces Price Target of $55

In the first quarter of 2025, earnings are expected to remain weak due to delayed entry into the flagship system-on-a-chip (SoC) market. However, demand for core products such as image sensors and DDI is expected to increase on the back of flagship smartphone launches.
Looking ahead to the first quarter of 2025, earnings are expected to remain weak due to sluggish mobile demand and fixed-cost burden stemming from lower utilization rates.
 &nbsp;

Guidance

SSNLF

Reported Earlier, Samsung Expects Overall Memory Market Demand To Recover From Q2; Expects Earnings To Remain Weak In Q1

JP Morgan analyst Jeffrey Zekauskas upgrades Avery Dennison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVY#NYSE">AVY</a>) from Neutral to Overweight and lowers the price target from $210 to $205.

Upgrades

JP Morgan Upgrades Avery Dennison to Overweight, Lowers Price Target to $205

Baird analyst Benjamin Hartford downgrades United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) from Outperform to Neutral and lowers the price target from $160 to $130.

Downgrades

Baird Downgrades United Parcel Service to Neutral, Lowers Price Target to $130

The Company posted KRW 75.8 trillion in consolidated revenue and KRW 6.5 trillion in operating profit in the quarter ended December 31, 2024. For the full year, it reported KRW 300.9 trillion in annual revenue and KRW 32.7 trillion in operating profit.
 &nbsp;

Earnings

Reported Earlier, Samsung Electronics Says Q1 Overall Earnings Improvement May Be Limited Due To Weakness In Semiconductors Business

Jefferies analyst Christopher LeFemina initiates coverage on Core Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNR#NYSE">CNR</a>) with a Hold rating and announces Price Target of $93.

Jefferies Initiates Coverage On Core Natural Resources with Hold Rating, Announces Price Target of $93

Canaccord Genuity analyst Sumant Kulkarni downgrades Intra-Cellular Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITCI#NASDAQ">ITCI</a>) from Buy to Hold and raises the price target from $119 to $132.

ITCI

Canaccord Genuity Downgrades Intra-Cellular Therapies to Hold, Raises Price Target to $132

Global payment technology companies, Mastercard Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) and Visa Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), which process credit card payments and other financial transactions reported better-than-expected quarterly earnings on Thursday. Shall investors buy, sell or hold these companies? Here&#8217;s what technical analysis suggests.
<h3 class="wp-block-heading">Technical Analysis Of Visa And Mastercard</h3>
Technical analysis suggests both Visa and Mastercard stocks are currently overbought, indicating a potential correction may be imminent, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. 
Visa shares closed Thursday at $343.05, significantly above its eight-day simple moving average of $331.69, 20-day average at $320.65, also 50 and 200-day averages of $316.42, and $285.73, respectively. The relative strength index of 80.35 further reinforces this overbought condition, suggesting recent rapid price increases may be unsustainable.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043122/VISA-tech-chart-1024x576.png" alt="" class="wp-image-759794" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043122/VISA-tech-chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043122/VISA-tech-chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043122/VISA-tech-chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043122/VISA-tech-chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043122/VISA-tech-chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also: <a href="https://www.benzinga.com/news/earnings/25/01/43355517/visa-shares-rise-on-solid-q1-results-details">Visa Shares Rise On Solid Q1 Results: Details</a> 
Mastercard shares, on the other hand, also exhibited a similar trend, closing Thursday at $566.01. This price is well above its eight-day average of $541.60, and 20-day average of $526.54. Also, 50 and 200-day averages of $526.67 and $484.31, respectively. With an RSI of 76.67, Mastercard&#8217;s stock is also considered overbought, signaling potential exhaustion of upward momentum and a possible sell signal.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043127/Mastercard-tech-chart-1024x576.png" alt="" class="wp-image-759795" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043127/Mastercard-tech-chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043127/Mastercard-tech-chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043127/Mastercard-tech-chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043127/Mastercard-tech-chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043127/Mastercard-tech-chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also: <a href="https://www.benzinga.com/news/earnings/25/01/43345282/mastercard-q4-earnings-revenue-and-eps-beat-strong-growth-in-payments-and-cross-border-transactions">Mastercard Q4 Earnings: Revenue And EPS Beat, Strong Growth In Payments and Cross-Border Transactions</a>
<h3 class="wp-block-heading">Analyst Recommendations</h3>
Despite the warning signs from the technical analysis of daily moving averages, ratings based on analysts tracked by Benzinga have a consensus &#8216;buy&#8217; on both stocks.
Visa also enjoys a consensus &#8220;buy&#8221; rating. The average price target among <a href="https://www.benzinga.com/quote/V/analyst-ratings">34 analysts</a> is $324.06, with a range of $252 to $375. Recent ratings from Piper Sandler, BofA Securities, and Citigroup suggest a $351 target, implying a 0.90% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/V/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="379" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043240/Visa-ANR-1-1024x379.png" alt="" class="wp-image-759801" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043240/Visa-ANR-1-1024x379.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043240/Visa-ANR-1-300x111.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043240/Visa-ANR-1-768x284.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043240/Visa-ANR-1.png 1062w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also: <a href="https://www.benzinga.com/25/01/43376448/elon-musks-x-money-to-see-about-600-million-active-monthly-users-via-visa-direct-integration">Elon Musk&#8217;s &#8216;X Money&#8217; To See About 600 Million Active Monthly Users Via Visa Direct Integration: &#8216;Excited To Partner,&#8217; Says CEO</a>
For Mastercard, the average price target among <a href="https://www.benzinga.com/quote/MA/analyst-ratings">34 analysts</a> is $542.84, with estimates ranging from $424 to $654. Recent ratings from Piper Sandler, Citigroup, and Oppenheimer suggest a $587.67 target, implying a potential upside of 3.53%.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/MA/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="386" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043146/Mastercard-ANR-1-1024x386.png" alt="" class="wp-image-759797" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043146/Mastercard-ANR-1-1024x386.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043146/Mastercard-ANR-1-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043146/Mastercard-ANR-1-768x290.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/31043146/Mastercard-ANR-1.png 1060w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Price Action: Shares of Visa were up 1.41% and Mastercard advanced 0.29% in premarket on Friday. Whereas the exchange-traded fund tracking S&amp;P 500, SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was up 0.49% at $608.01.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/01/43377987/after-imposing-tariffs-on-canada-donald-trump-threatens-100-levy-on-brics-for-move-against-dollar-how-will-us-manage-production-from-slippers-to-ships-asks-expert">After Imposing Tariffs On Canada, Donald Trump Threatens 100% Levy On BRICS For Move Against Dollar: &#8216;How Will US Manage Production From Slippers To Ships?,&#8217; Asks Expert</a></li>
</ul>
Image Via Shutterstock

Analyst Color

Equities

Market Summary

Broad U.S. Equity ETFs

Futures

Technicals

Markets

ETFs

General

Mastercard Vs. Visa: Buy, Sell Or Hold? Here's What Technical Analysis Suggest

Qudian Announced Appointment Of Marcum Asia CPAs As Company's New Independent Registered Public Accounting Firm

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the &#8220;Neutral&#8221; zone on Thursday.
U.S. stocks settled higher on Thursday, with the Dow Jones index gaining more than 150 points as investors assessed the recent earnings reports from mega-cap tech stocks.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) reported weaker-than-expected fourth-quarter earnings and sales results. The company, meanwhile, said it expects its vehicle business to return to growth in 2025. Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) reported better-than-expected fourth-quarter sales results on Wednesday. Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) reported its second-quarter GAAP earnings of $3.23 per share, beating the $3.11 consensus estimate.
President Donald Trump confirmed Thursday the United States will impose 25% tariffs on imports from Canada and Mexico starting Saturday, Feb. 1.
On the economic data front, U.S. initial jobless claims fell by 16,000 from the previous week to 207,000 in the week ending January 25, compared to market estimates of 220,000. The U.S. economy expanded at an annualized rate of 2.3% in the fourth quarter, down from 3.1% in the previous quarter and versus market estimates of 2.6%.
Most sectors on the S&amp;P 500 closed on a positive note, with utilities, real estate and health care stocks recording gains on Thursday. However, information technology stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 169 points to 44,882.13 on Thursday. The S&amp;P 500 rose 0.53% to 6,071.17, while the Nasdaq Composite rose 0.25% at 19,681.75 during Thursday's session.
Investors are awaiting earnings results from Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>), Chevron Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) and Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) today.
At a current reading of 48.1, the index remained in the &#8220;Neutral&#8221; zone on Thursday, versus a prior reading of 46.5.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/43336168/jim-cramer-likes-this-tech-stock-terrific-business-niche-business">Jim Cramer Likes This Tech Stock: &#8216;Terrific Business, Niche Business&#8217;</a></li>
</ul>

Pre-Market Outlook

MSFT

TSLA

Dow Jumps Over 150 Points As Investors Monitor Earnings Reports; Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone

Shares of Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) rose sharply in today's pre-market trading after the company reported <a href="https://in.benzinga.com/news/earnings/25/01/43355688/apple-q1-earnings-revenue-beat-eps-beat-iphone-sales-slip-installed-base-climbs-to-all-time-high-our-best-quarter-ever">better-than-expected first-quarter results.</a>
Apple reported fiscal first-quarter revenue of $124.3 billion, beating analyst estimates of $124.13 billion. The iPhone maker reported first-quarter adjusted earnings of $2.40 per share, beating analyst estimates of $2.36 per share.
Apple shares gained 3.4% to $245.73 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Trident Digital Tech Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDTH#NASDAQ">TDTH</a>) gained 104% to $1.94 in pre-market trading after dipping 62% on Thursday.</li>
<li>Nauticus Robotics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) rose 63.4% to $2.55 in pre-market trading after announcing a partnership to advance subsea autonomy solutions.</li>
<li>Diginex Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGNX#NASDAQ">DGNX</a>) gained 40% to $49.01 in pre-market trading after dipping 30% on Thursday.</li>
<li>Orangekloud Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORKT#NASDAQ">ORKT</a>) gained 37.2% to $1.88 in pre-market trading. Maxim Group analyst Allen Klee initiated coverage on Orangekloud Technology with a Buy rating and announced a price target of $5.</li>
<li>Cyclerion Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCN#NASDAQ">CYCN</a>) rose 25.1% to $3.18 in pre-market trading after gaining 7% on Thursday.</li>
<li>Envirotech Vehicles, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVTV#NASDAQ">EVTV</a>) shares jumped 17.7% to $0.4077 in pre-market trading after dipping 48% on Thursday. Envirotech Vehicles recently announced it has received orders for 48 vehicles to New Jersey.</li>
<li>Cipher Mining Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) gained 20.9% to $5.68 in pre-market trading after the company announced a $50 million investment from Softbank.</li>
<li>Atlassian Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) rose 18.9% to $317.40 in pre-market trading after the company reported better-than-expected second-quarter financial results.</li>
<li>Kimball Electronics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KE#NASDAQ">KE</a>) gained 11% to $20.11 in pre-market trading. Kimball Electronics will report second quarter fiscal year 2025 financial results on Tuesday, Feb. 4, 2025, after the closing bell.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Aviat Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVNW#NASDAQ">AVNW</a>) shares fell 46.5% to $10.00 in pre-market trading. Aviat Networks will release its second quarter fiscal 2025 financial results for the period ended Dec. 27, 2024, on Feb. 4, 2025, after the closing bell.</li>
<li>Enveric Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) dipped 39.7% to $2.35 in pre-market trading after the company priced $5 million public offering of 1.67 million common stock &amp; warrants at $3.00/share.</li>
<li>Stabilis Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNG#NASDAQ">SLNG</a>) shares fell 19.7% to $6.00 in pre-market trading.</li>
<li>Klotho Neurosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) fell 19.1% to $0.3202 in today's pre-market trading.</li>
<li>Benson Hill, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHIL#NASDAQ">BHIL</a>) shares dipped 18.7% to $3.21 in pre-market trading. Benson Hill shares jumped 119% on Thursday after the company announced results from a controlled broiler feeding trial conducted with Tyson Foods.</li>
<li>American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) shares tumbled 17.8% to $8.01 in pre-market trading.</li>
<li>Deckers Outdoor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) fell 15.1% to $189.32 in pre-market trading after the company reported third-quarter results.</li>
<li>Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) fell 10.4% to $10.28 in pre-market trading after the company suspended its quarterly dividend.</li>
<li>Beazer Homes USA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BZH#NYSE">BZH</a>) declined 8.6% to $25.33 in pre-market trading following worse-than-expected reported first-quarter financial results.</li>
<li>Olin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) fell 8.4% to $29.44 in pre-market trading following fourth-quarter earnings results.</li>
</ul>
Now Read This:
<ul>
<li><a href="https://www.benzinga.com/25/01/43335398/wall-streets-most-accurate-analysts-spotlight-on-3-risk-off-stocks-delivering-high-dividend-yields"> Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Risk Off Stocks Delivering High-Dividend Yields</a></li>
</ul>

Movers

AAPL

AVNW

BHIL

CIFR

CYCN

DECK

DGNX

ENVB

EVTV

KITT

KLTO

ORKT

SLNG

TDTH

TEAM

Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

On Thursday, Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) launched its RTX 5090 and 5080 graphics cards, only to see them sell out almost immediately.
What Happened: The highly anticipated Nvidia Series 5000 GPUs sold out rapidly, leaving many gamers frustrated, <a href="https://in.ign.com/nvidia-rtx-5080/223698/news/nvidia-rtx-5090-and-5080-sell-out-instantly-and-scalpers-are-already-cashing-in-with-6000-ebay-listi">reported</a> IGN. The GPUs were anticipated to have limited availability, a fact Nvidia had previously warned about.
Despite the warning, eager buyers lined up at <a href="https://www.benzinga.com/tech/25/01/43242360/jensen-huang-mania-mirrors-taylor-swift-people-are-camping-outside-retailers-for-nvidia-5000-series-gpus">U.S. distributor Micro Center</a>, hoping to secure one of the coveted cards.
However, the limited stock led to scalpers listing the RTX 5090 on eBay for over $6,000, a significant markup from its $1,999 MSRP, the report noted.
See Also: <a href="https://www.benzinga.com/markets/25/01/43377131/tim-cook-wont-say-how-apple-plans-to-handle-trumps-tariff-policies-but-heres-whats-at-stake-for-the-iphone-maker">Tim Cook Won&#8217;t Say How Apple Plans To Handle Trump&#8217;s Tariff Policies — But Here&#8217;s What&#8217;s At Stake For The iPhone Maker</a>
Third-party manufacturers also increased prices, with the Asus ROG Astral model reaching $2,799.
As a result, gamers expressed their frustration online, with some calling it a &#8220;paper launch&#8221; due to the lack of available stock.
Why It Matters: The scarcity of these GPUs is partly due to a design flaw in Nvidia&#8217;s Blackwell-based processors. This flaw affected production yields, impacting the availability of the RTX 5090 and 5080.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Nvidia&#8217;s focus on data center chips, which share the same manufacturing process, further strained consumer GPU production, the report stated.
Nvidia is expected to report its fourth-quarter earnings on Feb. 26. Last quarter, it posted a <a href="https://www.benzinga.com/news/earnings/24/11/42099904/nvidia-beats-q3-revenue-eps-estimates-supply-constraints-ding-stock-huang-says-age-of-ai-is-in-full-steam">revenue of $35.1 billion</a>, marking a 94% year-over-year surge and surpassing Wall Street's consensus estimate of $33.12 billion.
Price Action: Nvidia&#8217;s stock dipped 1.16% in pre-market trading to $123.20 on Friday after closing at $124.65 up 0.77% during regular hours on Thursday, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/43221770/apples-ipad-turns-15-today-heres-a-throwback-to-when-steve-jobs-explained-called-it-the-third-category-after-phones-and-notebooks" target="_blank" rel="noreferrer noopener">Apple's iPad Turns 15 Today: Here's A Throwback To When Steve Jobs Explained Called It The ‘Third Category' After Phones And Notebooks</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Tech

Media

NVDA

Nvidia RTX 5090 And 5080 Sell Out Instantly — Scalpers Jack Up Prices To $6,000 As Gamers Face 'Paper Launch' Frustration

Macro Economic Events

Econ #s

Economics

Germany Unemployment Rate For January 6.2% Vs. 6.2% Est.; 6.1% Prior

Germany Unemployment Change For January 11K Vs. 14K Est.; 10K Prior

Stifel analyst J. Bruce Chan upgrades C.H. Robinson Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) from Hold to Buy and maintains the price target from $113 to $113.

CHRW

Stifel Upgrades C.H. Robinson Worldwide to Buy, Maintains Price Target to $113

Former Department of Government Efficiency (DOGE) co-leader Vivek Ramaswamy has clarified his departure from the organization, emphasizing a strategic pivot toward elected office while <a href="https://www.benzinga.com/news/25/01/43078027/vivek-ramaswamy-expected-to-exit-trumps-doge-task-force-amid-ohio-governor-bid-report">addressing speculation about his relationship</a> with Tesla Inc. CEO Elon Musk.
What Happened: Speaking on the Flagrant podcast, Ramaswamy detailed his evolving approach to government reform. &#8220;If you want to save a lot of money, you got to do it through legislation,&#8221; Ramaswamy said, highlighting his focus on legal and constitutional issues.
The entrepreneur-turned-politician defended his exit, which had sparked rumors of tension with Musk, by explaining the natural divergence in their approaches. While Musk continues to lead DOGE&#8217;s technology-centric strategy, Ramaswamy expressed his intention to pursue reform through elected office, particularly at the state level.
During the interview, Ramaswamy criticized the current regulatory landscape, pointing to unelected bureaucrats&#8217; outsized influence on policy. &#8220;Most of the laws that decide what you can and can&#8217;t do in your life were actually never passed by Congress,&#8221; he noted, citing examples ranging from fishing licenses to nuclear plant permissions.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Vivek: Kicked out of DOGE? Elon Beef? Trump Relationship and More" width="500" height="281" src="https://www.youtube.com/embed/6dOfkRLWD7M?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
See Also: <a href="https://www.benzinga.com/government/regulations/25/01/43377987/after-imposing-tariffs-on-canada-donald-trump-threatens-100-levy-on-brics-for-move-against-dollar-how-will-us-manage-production-from-slippers-to-ships-asks-expert">After Imposing Tariffs On Canada, Donald Trump Threatens 100% Levy On BRICS For Move Against Dollar: &#8216;How Will US Manage Production From Slippers To Ships?,&#8217; Asks Expert</a>
Why It Matters: While stopping short of a formal announcement, Ramaswamy indicated his political aspirations would be revealed &#8220;in the next couple of weeks.&#8221; His comments particularly highlighted the governor&#8217;s role in driving executive action, suggesting a potential bid for Ohio&#8217;s governorship.
The transition marks a significant shift for Ramaswamy, who sees state-level executive positions as crucial leverage points for implementing meaningful government reform. His focus appears to be on addressing both federal and state-level regulatory challenges through elected office rather than through organizational reform efforts.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/43377455/trumps-tariffs-could-force-us-to-buy-venezuelan-oil-theres-no-other-option-on-the-table-says-canadas-foreign-minister">Trump&#8217;s Tariffs Could Force US To Buy Venezuelan Oil: &#8216;There&#8217;s No Other Option On The Table,&#8217; Says Canada&#8217;s Foreign Minister Melanie Joly</a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Government

Social Media

Vivek Ramaswamy Clarifies DOGE Exit Amid Speculation Of Sour Ties To Elon Musk, Shifts Focus To Ohio Governorship Bid: 'You Have to Do It Through Legislation'

NIO Says Has Completed Its Previously Announced Repurchase Right Offer Relating To Its 0.50% Convertible Senior Notes Due 2027

Goldman Sachs analyst Michael Ng maintains Comcast (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) with a Buy and lowers the price target from $50 to $44.

CMCSA

Goldman Sachs Maintains Buy on Comcast, Lowers Price Target to $44

EV giant Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has marked the option for white interiors as sold out on its launch series of the refreshed <a href="https://www.benzinga.com/tech/25/01/43221344/tesla-model-y-pricing-evolution-cuts-hikes-refreshes-over-two-years">Model Y vehicle</a> in the U.S., even before deliveries have commenced. 
What Happened: Tesla launched the refreshed Model Y in the U.S.<a href="https://www.benzinga.com/tech/25/01/43183608/tesla-launches-refreshed-model-y-in-us-with-25-price-hike-full-self-driving-included"> earlier this month</a>. Deliveries of the launch series of the long-range all-wheel drive variant of the refreshed vehicle, priced at $59,990, are slated to start in March. 
Launch series refers to a limited edition of the vehicle with exclusive badging and more that the company intends to make to celebrate the start of production. 
However, the option for customizing the Launch series vehicle with white interiors is already marked as sold out on Tesla&#8217;s U.S. website. Customers now have only the option to opt for an all-black five-seat interior. 
As for exterior paint options, the company has listed just quicksilver, ultra red, pearl white multi-coat, and stealth grey in the U.S. In China, however, the company has also listed an option for glacier blue exterior paint on the vehicle. 
Why It Matters: Tesla CEO Elon Musk&nbsp;said on Wednesday that all of the company's many factories will start producing the new Model Y vehicle starting in February but will <a href="https://www.benzinga.com/25/01/43328898/elon-musk-warns-teslas-new-model-y-will-result-in-several-weeks-of-lost-production-for-ev-giant-in-q1">lose production in the days of retooling factory.</a>
The CEO also warned that margins will be impacted due to idle capacity and other ramp-related costs. However, these challenges will be overcome once production is ramped, he said.
While in the U.S., the refreshed vehicle is listed alongside older versions of the vehicle, in China, it replaced the older version. In both geographies, deliveries are slated to start in March.
Model Y is manufactured at Tesla's factory in California, as well as its gigafactories in Shanghai, Berlin, and Texas. 
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43375903/tesla-researcher-estimates-drop-in-ev-deliveries-for-2025-despite-promise-of-new-models">Tesla Researcher Predicts Drop In Deliveries For Elon Musk&#8217;s EV Giant In 2025 Despite New Model Launches</a></li>
<li></li>
</ul>
Image via Tesla

Tesla Marks White Interiors On Launch Series Of Refreshed Model Y As Sold Out Before Deliveries Begin

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Sera Prognostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/sera-stock-quote/">SERA</a>) just reported results for the second quarter of 2024.<ul><li>Sera Prognostics reported earnings per share of -25 cents. This was above the analyst estimate for EPS of -26 cents.</li><li>The company reported revenue of $24,000.</li><li>This was 70% worse than the analyst estimate for revenue of $80,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/sera-stock-earnings-sera-prognostics-for-q2-of-2024/">SERA Stock Earnings: Sera Prognostics Beats EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SERA Stock Earnings: Sera Prognostics Beats EPS, Misses Revenue for Q2 2024

TD Cowen analyst Daniel Brennan maintained a Buy rating on Sera Prognostics (SERA – Research Report) today. The company's shares closed yesterday a...

TD Cowen Sticks to Their Buy Rating for Sera Prognostics (SERA)

Sera Prognostics, Inc. (SERA) Q2 2024 Earnings Call Transcript

Sera Prognostics GAAP EPS of -$0.24 misses by $0.02, revenue of $0.02M misses by $0.08M

Sera Prognostics, Inc. ( ($SERA) ) has released its Q3 earnings. Here is a breakdown of the information Sera Prognostics, Inc. presented to its inv...

Sera Prognostics Reports Strategic Moves Amid Revenue Decline

Sera Prognostics Inc (SERA) Q3 2024 Earnings Call Transcript

Sera Prognostics, Inc. (SERA) has disclosed a new risk, in the Technology category. Sera Prognostics, Inc. faces a significant business risk due to...

Sera Prognostics Faces Business Continuity Risks Amid Data Dependency

TD Cowen analyst Daniel Brennan maintained a Buy rating on Sera Prognostics (SERA – Research Report) today. The company's shares closed today at $6...

TD Cowen Reaffirms Their Buy Rating on Sera Prognostics (SERA)

Sera Prognostics ( ($SERA) ) has provided an announcement. On January 6, 2025, a study abstract published by the Society for Maternal Fetal Medicin...

Sera Prognostics Advances Maternal Health Research Initiatives

Sera Prognostics ( ($SERA) ) has shared an announcement. Sera Prognostics announced the release of a new investor presentation and its participatio...

Sera Prognostics Highlights PreTRM® at Healthcare Conference

Press Releases

SERA PROGNOSTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024

Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2024 Financial Results on November 6, 2024

SERA PROGNOSTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Sera Prognostics to Present at Piper Sandler 36th Annual Healthcare Conference

Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting

Sera Prognostics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Sera Prognostics to Host Virtual R&D Day on January 31

Abeona Therapeutics

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share

Amarin Corp

Anika Therapeutics

Benitec Biopharma

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

Cidara Therapeutics

Foghorn Therapeutics

Genfit

Gossamer Bio

TuHURA Biosciences

Inhibrx Biosciences

INmune Bio

Larimar Therapeutics, Inc. - Common Stock

Larimar Therapeutics

Lexeo Therapeutics

Macrogenics

Molecular Partners AG - American Depositary Shares

Molecular Partners

Neurogene

Ocugen

Protalix BioTherapeutics, Inc. (DE) Common Stock

Protalix BioTherapeutics

ProKidney Corp. - Class A Ordinary Shares

ProKidney

AVITA Medical

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

Tevogen Bio Holdings

Citigroup

Oppenheimer

Berenberg

매주, ‘벤징가의 스톡 위스퍼 지수(Benzinga's Stock Whisper Index)'는 독점 데이터(proprietary data)와 패턴 인식의 조합을 사용하여 <a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">표면 바로 아래에서 주목</a>을 받을 만한 주식 5종목을 소개한다.
투자자들은 가치가 저평가된, 관심이 적은, 새로운 주식들을 항상 찾고 있다. 소매 거래자들이 사용할 수 있는 방법은 무수히 많기 때문에 새로운 기회를 발견하고 특정 주식이 관심을 가져야 하는 이유를 이해하기 위해 풍부한 정보를 조사하는 것이 어려운 경우가 많다.
다음은 11월 1일 주간 벤징가 &#8216;주식 위스퍼&#8217; 지수의 개요:
애질런트 테크놀로지스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>):
투자자들의 관심이 증가하고 있으며, 이는 여러 잠재적 촉매제가 앞두고 있기 때문이다. 생명과학 및 진단 회사인 애질런트는 11월 25일에 4분기 재무 결과를 발표하고, 12월 17일에 애널리스트 데이를 개최할 예정이다. <a href="https://www.benzinga.com/quote/A/analyst-ratings" target="_blank" rel="noopener" data-google-interstitial="false">최근</a> 바클레이즈가 이 주식에 대해 비중축소(Underweight) 등급을 유지하면서 목표 주가를 135달러에서 145달러로 상향 조정한 후 주가가 상승했다. 에버코어 ISI는 인라인 등급을 유지하면서도 목표 주가를 135달러에서 145달러로 상향 조정했다. 주가는 금요일 5.03% 상승한 136.87달러에 마감했다. 지난 5거래일 동안 4.08% 상승했으며, 2024년 현재 연초 대비 1.35% 하락한 상태다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143840/Screenshot-227.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
트레이드 데스크(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>):
3분기 재무 결과 발표를 앞두고 투자자들의 관심이 증가했다. 11월 7일에 3분기 실적이 발표될 예정이며, 애널리스트들은 주당 39센트의 이익과 6억 1,980만 달러의 매출을 예상하고 있다. 이는 작년 3분기 주당 33센트의 이익과 4억 9,330만 달러의 매출과 비교된다. 트레이드 데스크는 최근 8개 분기 중 7개 분기에서 주당 이익 추정치를 초과했으며, 매출 추정치는 10개 분기 이상 초과했다.
웨드부시(Wedbush)의 애널리스트인 댄 아이브스는 트레이드 데스크의 성장 잠재력을 <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41144914/meta-trade-desk-amazon-digital-ad-titans-set-for-strong-2025-growth-tech-analyst-sa" target="_blank" rel="noopener" data-google-interstitial="false">강조</a>했다.
아이브스는 &#8220;우리 조사에 따르면 2분기 대비 3분기에 TTD의 성장이 가속화되는 것으로 나타났다&#8221;고 말했다.
트레이드 데스크의 <a href="https://www.benzinga.com/news/earnings/24/08/40267737/the-trade-desk-stock-climbs-after-better-than-expected-q2-results" target="_blank" rel="noopener" data-google-interstitial="false">2분기 실적</a>에 따르면 고객 유지율은 95%가 넘으며 10년 연속 이어졌다. 잠재적인 강력한 성장과 인공지능(AI) 이니셔티브가 통합되면서 주식은 3분기 실적에 대해 약간의 화제를 불러일으킬 수 있다.
주가는 금요일 0.85% 하락한 119.19달러에 마감되었다. 지난 5일 동안 0.82% 하락했으나, 2024년 연초 대비 68.85% 상승했다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143856/Screenshot-228.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
Schwab US Dividend Equity ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHD#NYSE">SCHD</a>):
이 ETF가 처음으로 리스트에 등장했다. 스톡 위스퍼 지수는 일반적으로 주식만 강조하고 ETF는 제외하지만, 매주 SPY, QQQ와 같은 잘 알려진 ETF들이 변동성을 기반으로 관심이 상승하는 경우가 있다. 슈왑(Schwab)은 Dow Jones U.S. Dividend 100 Index를 추적한다. 이는 배당금을 지급하고 배당금 지급 실적이 우수한 미국 대기업들에 대한 노출을 제공한다. 이 ETF의 주요 보유 종목에는 브리스톨 마이어스 스퀴브(Bristol Myers Squibb), 블랙록, 시스코 시스템즈, 홈 디포 및 쉐브론이 포함된다.
글로벌 긴장 고조, 거시경제 불확실성, 2024년 대통령 선거로 인해 일부 투자자들이 불안해하는 상황에서, 이 ETF가 배당 소득과 블루칩 회사들에 대한 투자로 인해 관심이 증가하고 있을 수 있다.
이 ETF는 금요일 0.46% 하락한 28.10달러에 마감되었다. 올해 들어 9.94% 올랐다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143913/Screenshot-229.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
리인슈런스 그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>):
생명 및 건강 재보험 회사로, 분기 재무 <a href="https://investor.rgare.com/news-releases/news-release-details/reinsurance-group-america-reports-record-third-quarter-results" target="_blank" rel="noopener">결과</a>로 인해 투자자들의 관심이 증가했다. 이 회사는 3분기 주당 6.13달러의 이익과 56억 5천만 달러의 매출을 기록했으며, 이는 월스트리트 컨센서스 예상을 초과한 결과이다. 리인슈런스 그룹의 3분기는 기록적인 재무 결과를 기록했다. 이 강력한 분기는 주식이 향후 성장 기회에 대한 투자자들의 레이더에 오르는 데 도움이 될 수 있다.
주가는 금요일 1.90% 상승한 215.10달러에 마감되었다. 지난 5일 동안 1.37% 상승했으며, 2024년 연초 대비 31.83% 상승했다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01143928/Screenshot-230.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
세라 프로그노스틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERA#NASDAQ">SERA</a>):
3분기 재무 결과를 11월 6일에 발표할 예정이다. 이 회사는 임신 조기 출산 테스트를 위한 PreTRM 테스트를 개발했다. 투자자 발표에서는 이 회사의 미래 제품 파이프라인에 대한 설명도 있었으며, 예측 분석 제품과 출산 시기 테스트가 포함될 예정이다.
이 임신 진단 회사의 주가는 금요일 1.56% 상승한 7.81달러에 마감되었다. 지난 5거래일 동안 16.57% 상승했다. 2024년 연초 대비 30.82% 상승했다.
다음 주 보고서를 계속 지켜봐 주시기 바랍니다. 여기에서 Benzinga Pro를 팔로우하여 모든 최신 헤드라인과 <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102524&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">시장을 움직이는 주요 스토리</a>를 확인하세요.
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Sera Prognostics

뉴스

에 대한 최신 뉴스 Sera Prognostics (NASDAQ:SERA) 주식

토요일, 11월 02, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌